Microfluidics Market Projected to Reach $20.73 Billion by 2030
The microfluidics market is projected to grow from $10.33 billion in 2025 to $20.73 billion by 2030. Growth is tied to lab-on-a-chip research, miniaturized diagnostics, and pharmaceutical R&D adoption.
The microfluidics market is projected to surge from $10.33 billion in 2025 to $11.89 billion in 2026 with a CAGR of 15%, and is further expected to reach $20.73 billion by 2030. Growth is driven by increased lab-on-a-chip research, demand for miniaturized diagnostics, pharmaceutical R&D adoption, and expansion in clinical testing and device advancements.
Key developments include the adoption of microfluidics in point-of-care diagnostics, personalized medicine, polymer-based microfluidics, and high-throughput screening integrated with IoT and smart labs. Notable trends foresee microfluidics intertwining with drug delivery, clinical diagnostics, industrial solutions, and precision fluid manipulation technologies.
Clinical studies on cell-based therapies have underscored the utility of microfluidics, notably advancing biomanufacturing for drug, gene, and cell therapies. In July 2023, the American Society of Gene and Cell Therapy reported a 58% increase in non-oncology gene therapy trials, highlighting microfluidics' role in this domain.
Major players are innovating with lab-on-a-chip devices to enhance diagnostic accuracy and reduce processing times. In March 2024, Takara Bio launched a dissolvable microfluidic lentiviral transduction enhancer, offering improved gene delivery for therapy applications and simplifying experimental setups.
Corporate activity also highlighted the sector's momentum. In January 2025, bioMerieux acquired SpinChip Diagnostics ASA for USD 0.15 billion, aiming to expand its microfluidics-driven diagnostic capabilities by leveraging SpinChip's advanced technology for rapid, sensitive testing.
North America is the largest and fastest-growing region, with significant contributions also expected from Asia-Pacific and Europe. The market's scope encompasses molecular sensors, DNA analysis, and cell separation, with segments spanning silicon-based, glass-based, and polymer-based microfluidics and technologies including droplet-based, continuous-flow, digital, paper-based, centrifugal, and organ-on-a-chip platforms.